연구성과로 돌아가기
2022 연구자 정보 (910 / 1074)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lee, Ja-yeon (Lee, JY) |
Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Sch Med, Hwasun, Jeonranam Do, South Korea |
|
|
[JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca; | ||
|
Lee, Jae Hoon (Lee, JH) |
Gachon Univ, Gil Med Ctr, Seongnam, South Korea Gachon Univ, Gil Med Ctr, Incheon, South Korea Gachon Univ, Gil Med Ctr, Div Hematol, Coll Med, Incheon, South Korea |
AAC-4169-2022 JFA-4725-2023 Lee, Jeong Won Lee, Jeong |
|
[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study) [JCR상위 5.7] Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party [JCR상위 3.2] Role of Autologous or Allogeneic Stem Cell Transplantation in Patients with Peripheral T Cell Lymphomas (PTCLs) Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea |
SCIE ESCI |
3.2 |
HEMATOLOGY;ONCOLOGY HEMATOLOGY |
kihyunkimk@gmail.com;drjejung@chonnam.ac.kr; inkyung.joo@novartis.com;D.W.K.dwkim@eulji.ac.kr;dwkim@eulji.ac.kr; |
||
|
Lee, Je-Jung (Lee, JJ) |
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea Chonnam Natl Univ, Hwasun Hosp, Gwangju, South Korea Chonnam Natl Univ, Sch Med, Gwangju, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Sch Med, Hwasun, Jeonranam Do, South Korea Chonnam Natl Univ, Genom Res Ctr Hematopoiet Dis, Sch Med, Hwasun, Jeonranam Do, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Jeollanam Do, South Korea Chonnam Natl Univ, Sch Med, Hwasun Hosp, Gwangju, South Korea Chonnam Natl Univ, Hwasun Hosp, Med Sch, Hwasun, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Jeollanam Do, South Korea |
A-3892-2015 F-6974-2013 GLR-4153-2022 JFA-4725-2023 Lee, Sang-Jun Lee, Jung-Hye Lee, Yong Jae Lee, Jeong |
|
[JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia [JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma [JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms [JCR상위 35.1] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study) [JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia [JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study) [JCR상위 5.7] Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party [JCR상위 3.2] Prognostic Predictability of 2022 European Leukemianet (ELN) Risk Stratification in the Real World |
SCIE | 3.2 |
HEMATOLOGY;ONCOLOGY ONCOLOGY HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY |
jhmoon@knu.ac.kr; zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca; drjejung@chonnam.ac.kr;ckmin@catholic.ac.kr; f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; kihyunkimk@gmail.com;drjejung@chonnam.ac.kr; |
||
|
Lee, Ji-Hyun (Lee, JH) |
Dong A Univ, Coll Med, Seoul, South Korea |
ACF-1247-2022 Lee, Jinseok |
|
[JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study) | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | |||
|
Lee, Kyoo-Hyung (Lee, KH) |
Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea |
|
|
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr; | ||
|
Min, Chang-Ki (Min, CK) |
Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea Catholic Univ Korea, Seoul St Marys Hematol Hosp, Seoul St, Seoul, South Korea |
|
|
[JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma [JCR상위 35.1] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study) |
SCIE | 35.1 |
HEMATOLOGY;ONCOLOGY ONCOLOGY |
drjejung@chonnam.ac.kr;ckmin@catholic.ac.kr; | ||
|
Min, Jung-Joon (Min, JJ) |
Chonnam Natl Univ, Dept Nucl Med, Hwasun Hosp, Hwasun, South Korea |
|
|
[JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | jhmoon@knu.ac.kr; | ||
|
Moon, Joon Ho (Moon, JH) |
Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea Kyungpook Natl Univ, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea Kyungpook Natl Univ Hosp, Daegu, South Korea Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea |
|
0000-0003-3756-796X Moon, Joon-ho |
[JCR상위 65.2] Clinical impact of time to the best response in relapsed/refractory multiple myeloma patients receiving carfilzomib [JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline [JCR상위 63.9] Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia [JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma [JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms [JCR상위 35.1] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study) [JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia [JCR상위 44.2] Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD [JCR상위 65.2] Validation of new diagnostic criteria of primary plasma cell leukemia: a study of the Korean Multiple Myeloma Working Party (KMMWP-2003 study) [JCR상위 5.7] Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party [JCR상위 3.2] Prognostic Predictability of 2022 European Leukemianet (ELN) Risk Stratification in the Real World [JCR상위 3.2] Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study [JCR상위 3.2] Role of Autologous or Allogeneic Stem Cell Transplantation in Patients with Peripheral T Cell Lymphomas (PTCLs) |
SCIE | 3.2 |
HEMATOLOGY;ONCOLOGY HEMATOLOGY ONCOLOGY HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION CELL & TISSUE ENGINEERING;MEDICINE, RESEARCH & EXPERIMENTAL;TRANSPLANTATION |
jhmoon@knu.ac.kr; sksohn@knu.ac.kr; zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca; drjejung@chonnam.ac.kr;ckmin@catholic.ac.kr; f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; sksohn@knu.ac.kr;jhmoon@knu.ac.kr; kihyunkimk@gmail.com;drjejung@chonnam.ac.kr; |
||
|
Novitzky-Basso, Igor (Novitzky-Basso, I) |
Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada |
AAU-2356-2020 Novitzky-Basso, Igor |
0000-0003-3748-3117 Novitzky-Basso, Igor |
[JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca; | ||
|
Park, Hyunkyung (Park, H) |
제1저자 | Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea |
|
|
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr; | |
|
Park, Sang-Gon (Park, SG) |
Chosun Univ Hosp, Dept Internal Med, Gwangju, South Korea |
AAD-1328-2022 Park, Jinwoo |
|
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr; | ||
|
Park, Seonyang (Park, S) |
Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr; | ||
|
Sohn, Sang-Kyun (Sohn, SK) |
Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, 130 Dongdeok Ro, Daegu 41944, South Korea Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea |
|
|
[JCR상위 65.2] Clinical impact of time to the best response in relapsed/refractory multiple myeloma patients receiving carfilzomib [JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline [JCR상위 65.2] The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients |
SCIE | 65.2 | HEMATOLOGY;ONCOLOGY |
jhmoon@knu.ac.kr; ihkimmd@snu.ac.kr;sskimb@ssu.ac.kr; |
||
|
Son, Meong Hi (Son, MH) |
Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea |
|
|
[JCR상위 65.2] Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms | SCIE | 65.2 | HEMATOLOGY;ONCOLOGY | hjoonk@chonnam.ac.kr;zhaolei.zhang@utoronto.ca;dr.dennis.kim@uhn.ca; | ||
|
Song, Ga-Young (Song, GY) |
Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea Chonnam Natl Univ, Hwasun Hosp, Gwangju, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Jeollanam Do, South Korea Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Jeollanam Do, South Korea Chonnam Natl Univ Med Sch, Hwasun Hosp, Dept Internal Med, Jeollanam Do, South Korea |
|
|
[JCR상위 65.2] Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On ¹⁸F-FDG PET/CT at Baseline Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia [JCR상위 65.2] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma [JCR상위 35.1] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study) [JCR상위 21.2] Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia [JCR상위 3.2] Prognostic Predictability of 2022 European Leukemianet (ELN) Risk Stratification in the Real World [JCR상위 3.2] Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study |
SCIE | 3.2 |
HEMATOLOGY;ONCOLOGY ONCOLOGY HEMATOLOGY;IMMUNOLOGY;ONCOLOGY;TRANSPLANTATION HEMATOLOGY |
jhmoon@knu.ac.kr; zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; drjejung@chonnam.ac.kr;ckmin@catholic.ac.kr; f0115@chonnam.ac.kr;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca; |
페이지 이동: